{
    "2016-03-23": [
        "Regeneron and Sanofi Announce Positive Topline Results from Phase 3 Praluent Study in Patients Undergoing LDL Apheresis Therapy",
        "Regeneron and Sanofi: Praluent Study Meets Goal in LDL Apheresis Therapy Patients"
    ]
}